cannabinoid K2

use is associated with myocardial infarction

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Myocardial Ischemia (Ischemic Heart Diseases) 09/01/2015 - "Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients."
2.	Pericarditis 12/01/2015 - "Synthetic cannabinoid (K2) use in pediatric patients and cardiovascular events: A place for pericarditis and myopericarditis?"
3.	Pain (Aches) 06/01/2016 - "After some delay, it was discovered that he had been using a synthetic cannabinoid (K2) which may have precipitated his pain crisis and, with hindsight, explained his prolonged period of delirium. "
4.	Myocardial Infarction 12/01/2011 - "Myocardial infarction associated with use of the synthetic cannabinoid K2."
5.	Delirium 06/01/2016 - "After some delay, it was discovered that he had been using a synthetic cannabinoid (K2) which may have precipitated his pain crisis and, with hindsight, explained his prolonged period of delirium. "